Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Dec 23, 2021 11:57am
509 Views
Post# 34258191

RE:Elective surgeries postponed

RE:Elective surgeries postponed Becker's ASC = ambulatory surgery centers nationwide

That was true in June and Sept. 2021, months after Delta was kind of under control, even before the Omicron variant was known!

June 1st - 106 hospitals postponing elective procedures amid the COVID-19 resurgence

Sept. 1st - UNC Health Southeastern to postpone some elective surgeries

This decision is one being made all across North Carolina right now. 




Today's Top 20 Stories
  1. Here's where nonurgent surgeries are being delayed

    Hospitals nationwide are again delaying nonurgent surgeries amid rising COVID-19 cases and the global spread of the omicron variant.





It is even more of a reality since Omicron started spreading, as per Dec. 9:

This study didn't even consider Omicron!!!

Projecting COVID-19 disruption to elective surgery - The Lancet


7 days ago — Millions of elective surgical procedures were cancelled worldwide ... elective surgery activity from December, 2021, to February, 2022, ...




7 days ago — Millions of elective surgical procedures were cancelled worldwide ... elective surgery activity from December, 2021, to February, 2022, ...

Published:December 16, 2021

Millions of elective surgical procedures were cancelled worldwide during the first wave of the COVID-19 pandemic.
 This enabled redistribution of staff and resources to provide care for patients with COVID-19 and addressed evidence that perioperative SARS-CoV-2 infection increases postoperative mortality.
 Although some hospitals established COVID-19-free surgical pathways to create safe elective surgery capacity,
 the National Health Service (NHS) in England has not returned to pre-pandemic elective surgery activity levels.
The NHS faces winter pressures every year but enters this winter in a particularly fragile state.
 The emergence of the omicron SARS-CoV-2 variant raises the possibility of rapid increases in COVID-19 admissions and intensified pressure on elective care. We used NHS England activity data from the period following the end of the first COVID-19 wave (ie, from September, 2020, onwards) to estimate how increases in the number of hospital beds occupied by COVID-19 inpatients at any one time might affect elective surgery activity in England over the coming winter months. We calculated the potential shortfall in projected elective surgery activity from December, 2021, to February, 2022, compared to the same period in 2019 before the COVID-19 pandemic. Full methodology is described in the appendix.

<< Previous
Bullboard Posts
Next >>